Hi Community
I am trying to figure out our post-market surveillance requirements for our IIa/IIb CE-marked (legacy devices) but in Canada (they also are on the market there already).
I have been reading the latest canadian guidance and I find no significant differences from MDR's PSUR. Since we already have that ready for our MDR submission do you think I could just change the compliance statement and submit the same document? Anyone has any experience/feedback from Health Canada after submitting a PSUR as a Summary Report? Or even better does anyone have any comments on the differences of the 2 documents?
Thank you all for the precious help
I am trying to figure out our post-market surveillance requirements for our IIa/IIb CE-marked (legacy devices) but in Canada (they also are on the market there already).
I have been reading the latest canadian guidance and I find no significant differences from MDR's PSUR. Since we already have that ready for our MDR submission do you think I could just change the compliance statement and submit the same document? Anyone has any experience/feedback from Health Canada after submitting a PSUR as a Summary Report? Or even better does anyone have any comments on the differences of the 2 documents?
Thank you all for the precious help